Cargando…
PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging
The development of novel PET imaging agents for synaptic vesicle glycoprotein 2A (SV2A) allowed for the in vivo detection of synaptic density changes, which are correlated with the progression and severity of a variety of neuropsychiatric diseases. While multiple ongoing clinical investigations usin...
Autores principales: | Toyonaga, Takuya, Fesharaki-Zadeh, Arman, Strittmatter, Stephen M., Carson, Richard E., Cai, Zhengxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957200/ https://www.ncbi.nlm.nih.gov/pubmed/35345546 http://dx.doi.org/10.3389/fnins.2022.787404 |
Ejemplares similares
-
Feasibility of imaging synaptic density in the human spinal cord using [(11)C]UCB-J PET
por: Rossano, Samantha, et al.
Publicado: (2022) -
The Rise of Synaptic Density PET Imaging
por: Becker, Guillaume, et al.
Publicado: (2020) -
PET Imaging in Animal Models of Alzheimer’s Disease
por: Chen, Baosheng, et al.
Publicado: (2022) -
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [(18)F]SDM-16
por: Zheng, Chao, et al.
Publicado: (2023) -
Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [(11)C]UCB‐J
por: Mecca, Adam P., et al.
Publicado: (2022)